Diabetes in Dogs (Canine Diabetes Mellitus): Insulin, Monitoring, DKA, and Prognosis
Canine diabetes mellitus — why dogs need lifelong insulin, how it's diagnosed, Vetsulin vs ProZinc vs NPH, blood glucose curves, fructosamine, diabetic cataracts, and DKA warning signs.
Diabetes mellitus is one of the most common hormonal diseases of dogs, with an estimated prevalence of roughly 0.3% to 1.3% worldwide, and it appears to be rising. In 2026 the American Animal Hospital Association (AAHA) published its first-ever diabetes guidelines written specifically for cats — and explicitly split dogs and cats into separate documents because the two species now need such different management. The 2026 AAHA Diabetes Management Guidelines for Dogs is expected later this year; until then, the 2018 AAHA Diabetes Management Guidelines for Dogs and Cats remain the standing reference for canine patients.
The reason the species were separated is the crux of this article: almost all diabetic dogs have an insulin-deficient, type-1-like disease and require lifelong insulin injections, whereas many cats have a type-2-like disease that can sometimes be managed without insulin or even sent into remission. A dog owner researching "pet diabetes" online will mostly find cat-oriented advice about low-carbohydrate diets and pills — and most of it does not apply to dogs. This guide covers the canine side: what the disease is, how it is diagnosed, the insulin options veterinarians actually choose between, how monitoring works, the complications that matter (especially cataracts and diabetic ketoacidosis), and what long-term prognosis looks like.
Quick answer
Canine diabetes mellitus is a loss of the pancreatic beta cells that make insulin, producing persistent high blood glucose. It is diagnosed from the combination of classic signs — increased thirst and urination, increased hunger, and weight loss — with persistent fasting high blood glucose and glucose in the urine, and it is usually confirmed with a fructosamine test that reflects average glucose over the prior two to three weeks. Because the disease in dogs is overwhelmingly insulin-dependent, treatment is lifelong twice-daily (sometimes once-daily) insulin injections, paired with a consistent diet, feeding schedule, and exercise. With owner commitment and veterinary follow-up, most diabetic dogs live a full, good-quality life. The two emergencies to know are hypoglycemia (low blood sugar, usually from a missed meal or an insulin/dose error) and diabetic ketoacidosis (DKA), a life-threatening complication marked by vomiting, lethargy, dehydration, and a sweet or acetone odor to the breath.
What diabetes is, and why dogs get it
Insulin is the hormone that lets cells take glucose out of the bloodstream for fuel. Without enough insulin, glucose piles up in the blood while the cells starve. The kidneys spill the excess glucose into the urine, dragging water with it (which causes the dramatic thirst and urination), and the body breaks down fat and muscle for fuel instead (which causes the weight loss and increased hunger despite eating).
In dogs, the beta-cell loss is usually immune-mediated — the body destroys its own insulin-producing cells — and is structurally and behaviorally similar to type 1 diabetes in people. A true type-2 (insulin-resistance, obesity-driven) diabetes as understood in humans and cats does not really occur in dogs; obesity contributes insulin resistance but rarely progresses to overt diabetes unless another trigger is present. Some dogs develop diabetes secondary to chronic or recurrent pancreatitis (which damages the insulin-producing tissue) or to other hormonal conditions that antagonize insulin, especially hyperadrenocorticism (Cushing's disease) and, less often, hypothyroidism. Intact (unspayed) females can also develop insulin resistance during the diestrus phase of their cycle, which is why spaying is part of the workup for some newly diagnosed females.
Typical signalment: middle-aged to older dogs, often around 7 to 9 years, with a slight female predisposition in some populations. Certain breeds are overrepresented (for example, Miniature Schnauzers, Poodles, Dachshunds, Beagles, Samoyeds, and Australian Terriers in various studies), but any dog can be affected.
Signs that prompt the diagnosis
Most owners bring the dog in for one or more of the "three Ps":
- Polyuria / polydipsia — dramatically increased urination and thirst (drinking the bowl dry, needing to go out at night)
- Polyphagia — increased hunger
- Weight loss despite a normal or increased appetite
Other common signs include lethargy, muscle wasting, a poor or unkempt coat, and — in some dogs — sudden blindness from cataracts (more below). Because several of these overlap with other diseases, the diagnosis is never made on signs alone.
How diabetes is diagnosed and what else gets ruled out
The diagnosis rests on persistent hyperglycemia plus glucosuria (glucose in the urine) in a dog with compatible clinical signs. A single elevated glucose reading is not enough, because stress can transiently raise blood glucose in dogs (though far less dramatically than in cats). Key pieces of the workup:
- Blood glucose, preferably fasting and repeated
- Urinalysis, to document glucose in the urine and to look for ketones and urinary tract infection (UTIs are common in diabetic dogs)
- Serum fructosamine, a protein that reflects average blood glucose over roughly the preceding two to three weeks — it is the test that separates true diabetes from a one-day stress spike
- A full chemistry panel and CBC (to assess organs, look for elevated liver enzymes, and screen for concurrent disease)
- Often a thyroid panel and Cushing's testing when clinical clues point to a contributing endocrinopathy, and sometimes pancreatic markers if pancreatitis is suspected
Fructosamine is the single most useful confirmatory test in a dog with borderline or confusing glucose values, and it becomes the backbone of long-term monitoring once insulin has been started.
Insulin: the options and how the choice is made
Insulin therapy is not optional for the vast majority of diabetic dogs — the question is which formulation and what schedule. In the United States, the insulins most commonly used in dogs are:
- Vetsulin (Caninsulin outside the U.S.) — a porcine lente insulin and the only product FDA-approved for use in dogs. Because porcine insulin is identical in amino-acid sequence to canine insulin, it is a logical first choice. It is given twice daily in most dogs (starting around 0.5 U/kg every 12 hours), must be resuspended by shaking before each dose, and produces two peaks of activity.
- ProZinc (protamine zinc recombinant human insulin) — FDA-licensed for dogs since 2019 (the second canine insulin after Vetsulin), after years of extra-label use. Its longer duration makes once-daily dosing effective in many dogs (label starting dose 0.5–1.0 IU/kg); in the 276-dog registration field study, the main owner-visible signs — excess urination and thirst — improved in roughly 90% of dogs within about three months.
- NPH insulin (Humulin N, Novolin N) — a human U-100 insulin and usually the least expensive option, given twice daily.
- Glargine (Lantus) and detemir (Levemir) — long-acting human basal insulins, also used in dogs, generally started twice daily. Detemir is potent, so small dogs need careful, low starting doses to avoid hypoglycemia.
A practical point owners often miss: the concentration differs between products. Vetsulin and ProZinc are U-40; NPH, glargine, and detemir are U-100. The syringes must match the insulin, or the dog receives the wrong dose — a common and dangerous dispensing error. Starting doses are deliberately conservative, and dose changes are made gradually based on monitoring, never by guessing at home.
This article does not give a universal dose. The right insulin, starting dose, and schedule depend on the individual dog and must be set and adjusted by your veterinarian.
Monitoring: glucose curves, fructosamine, and CGMs
A "well-regulated" diabetic dog is one whose clinical signs are controlled (normal thirst, stable weight, good energy) and who avoids both sustained high glucose and hypoglycemia. Veterinarians track this with several tools:
- The blood glucose curve (BGC) — serial blood glucose measurements every one to two hours across a day (often in-hospital) to see the insulin's peak ("nadir") and duration. Curves are done after any dose change and periodically thereafter.
- Serum fructosamine — the two-to-three-week average; ideal for checking long-term control once a dose has been stable for at least about three weeks.
- Continuous glucose monitors (CGMs) — small sensors applied to the skin, increasingly used in dogs to capture full days of data without repeated needle sticks and without the stress-hyperglycemia artifact that distorts in-hospital curves.
- Home monitoring — some owners are taught to check blood glucose at home with a pet-calibrated glucometer, which pairs well with CGMs.
A common target for "adequate control" is a glucose nadir roughly in the 80–125 mg/dL range with a peak below about 300 mg/dL and improvement in the three-P signs. The exact targets are individualized, and veterinary targets are more relaxed than human diabetes targets because the long-term vascular complications that drive tight control in people are not the main concern in dogs.
One pitfall veterinarians watch for is the Somogyi (rebound) effect — a dose that pushes glucose too low triggers a compensatory hormone surge that produces very high readings, which can be misread as "under-dosed" and then wrongly increased. When control suddenly worsens, lowering the dose is sometimes the right answer, which is why dose changes should always be guided by a curve, not a single reading.
Diet, weight, and routine
Diet matters in diabetic dogs, but mostly through consistency, not through a miracle formulation. The evidence that high-fiber diets dramatically improve canine glycemia is modest; what clearly helps is feeding the same food in the same amount at the same times, paired with insulin, so that glucose input and insulin action stay predictable. Food is typically offered immediately before each insulin injection so the owner can confirm the dog is eating and willing to eat before giving the dose. Moderate, consistent exercise helps; erratic heavy exercise can drop glucose precipitously. Weight management — reaching and holding a lean body condition — improves insulin sensitivity.
Complications that matter
Diabetic cataracts are the complication owners notice most. High blood glucose drives sorbitol accumulation in the lens, which draws in water, clouds the lens, and — in many dogs — leads to fairly rapid cataract formation and vision loss. Cataracts are common in diabetic dogs and can occur even in reasonably well-controlled patients; they are treatable with surgery by a veterinary ophthalmologist when owners pursue it, and blind dogs adapt remarkably well otherwise.
Hypoglycemia (low blood sugar) is the most immediate day-to-day risk, usually from a missed or vomited meal, an insulin dosing error, or excess exercise. Signs include weakness, hunger, wobbliness, tremors, behavior change, and — if severe — seizures or collapse. Owners are taught to keep a fast-sugar source (like corn syrup or a glucose gel) on hand and to call the veterinarian; severe hypoglycemia is an emergency.
Diabetic ketoacidosis (DKA) is the life-threatening emergency. When cells can't use glucose, the body overproduces ketones, the blood becomes acidic, and the dog decompensates. Signs include vomiting, anorexia, profound lethargy, dehydration, rapid breathing, and sometimes a sweet or acetone (nail-polish-remover) odor to the breath. DKA requires hospitalization — intravenous fluids, short-acting intravenous insulin, and careful electrolyte correction (especially potassium and phosphorus, which shift dangerously during treatment). Reported survival to discharge is roughly 70%, and DKA is more common in dogs with a concurrent illness such as pancreatitis, a urinary tract infection, or Cushing's disease.
Urinary tract infections, pancreatitis, and other endocrinopathies are common companions and can destabilize a previously well-controlled dog, which is why periodic urine cultures and recheck panels are part of long-term care.
Prognosis
With consistent, committed management and regular veterinary follow-up, a diabetic dog can live a good-quality life for years. Published median survival estimates commonly fall in the range of roughly 1 to 3 years after diagnosis, with wide variation — well-managed dogs without major complicating disease often live well beyond that, while dogs that present in DKA or with uncontrolled Cushing's disease or recurrent pancreatitis tend to do worse. Prognosis is best when an owner can reliably give twice-daily insulin, monitor, and keep diet and exercise consistent. The two things that shorten life are DKA and the conditions that destabilize control.
Be honest with yourself about the commitment before starting. Diabetes in dogs is not curable and cannot be managed without insulin — there is no oral alternative for type-1-like canine disease, and treatment is lifelong. Beyond the daily time commitment, owners should plan for ongoing cost: published owner-facing estimates put insulin itself at roughly $30 to $150 per month, with total care (insulin, syringes, prescription diet, and periodic bloodwork and curve/fructosamine rechecks) commonly reaching into the low thousands of dollars per year, especially during the initial months of regulation. Pet insurance with diabetes covered can offset much of this, subject to each policy's terms.
What to ask your veterinarian
- At diagnosis: "Which insulin do you recommend for my dog and why, what syringes and concentration do I need, and exactly how do I store, resuspend, and give it?"
- About monitoring: "Will we use in-hospital curves, fructosamine, a continuous glucose monitor, or home checks — and what glucose signs mean I should call you between visits?"
- About emergencies: "How do I recognize and treat hypoglycemia at home, and what are the DKA warning signs that mean I go straight to an emergency hospital?"
- About the bigger picture: "Should we screen for pancreatitis, Cushing's disease, or a urinary tract infection as part of getting my dog regulated?"
For related VetMedGuide workups, see our guides to feline diabetes monitoring (where management diverges sharply from dogs), canine Cushing's disease testing and trilostane monitoring (a common insulin-resistance comorbidity that must be controlled to regulate diabetes), and pancreatitis in dogs (a frequent concurrent disease that can both trigger and complicate diabetes).
Sources
- American Animal Hospital Association (AAHA). 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. https://www.aaha.org/resources/2018-aaha-diabetes-management-guideline-for-dogs-and-cats
- AAHA. Now available: 2026 AAHA Diabetes Management Guidelines for Cats (notes the split into separate canine and feline guidelines, with canine guidelines forthcoming). https://www.aaha.org/trends-magazine/publications/coming-soon-2026-aaha-diabetes-management-guidelines-for-cats
- Today's Veterinary Practice. Treating and Managing Diabetes Mellitus in Dogs. https://todaysveterinarypractice.com/endocrinology/treating-and-managing-diabetes-mellitus-in-dogs
- dvm360. The latest management recommendations for cats and dogs with nonketotic diabetes mellitus. https://www.dvm360.com/view/latest-management-recommendations-cats-and-dogs-with-nonketotic-diabetes-mellitus
- VCA Animal Hospitals. Diabetes Mellitus: Insulin Treatment in Dogs. https://vcahospitals.com/know-your-pet/diabetes-mellitus-insulin-treatment-in-dogs
- VCA Animal Hospitals. Diabetes Mellitus in Dogs — Overview (prognosis and management commitment). https://vcahospitals.com/know-your-pet/diabetes-mellitus-in-dogs-overview
- PetMD (DVM-authored). Diabetes in Dogs (lifelong insulin, cost and management goals). https://www.petmd.com/dog/conditions/endocrine/diabetes-dogs
- Boehringer Ingelheim Animal Health. PROZINC (protamine zinc recombinant human insulin) for canine diabetes (prescribing/start-dose information). https://animalhealth.boehringer-ingelheim.com/pets/canine/products/therapeutics/prozinc-for-canines
- NIH/National Library of Medicine (PMC). Update on insulin treatment for dogs and cats: insulin dosing pens and more. https://pmc.ncbi.nlm.nih.gov/articles/PMC6067590
- NIH/National Library of Medicine (PMC). Diabetes mellitus in dogs attending UK primary-care practices: frequency, risk factors and survival. https://pmc.ncbi.nlm.nih.gov/articles/PMC7288514
- Royal Canin Academy. Canine Diabetic Ketoacidosis. https://academy.royalcanin.com/en/veterinary/canine-diabetic-ketoacidosis
- PetMD (DVM-authored). Diabetic Ketoacidosis in Dogs. https://www.petmd.com/dog/conditions/endocrine/c_dg_diabetes_with_ketoacidosis
